欢迎来到天天文库
浏览记录
ID:49407664
大小:310.00 KB
页数:5页
时间:2020-03-01
《ACTH The forgotten therapy 促肾上腺皮质激素治疗的遗忘.doc》由会员上传分享,免费在线阅读,更多相关内容在工程资料-天天文库。
1、ELSEVIERSeminarsinCrossMarkContentslistsavailableatScienceDireciSeminarsinlmmunologyjournalhomepage:w*elsevici:com/loc2、iversityofl.ondon,ChartcrhouseSquaraEC1M6BQ.London,UniledKingdomarticleinfoArLiclehistory:Received14January2015Received!nrevisedform7February2015Accepted9February2015Althoughanti-inflammalorydrugsarcamongthemostcommonclassofmarketeddrugschronicinflam-matorycondit3、ionssuchasrheumatoidarthritismultiplesclerosisorinflammatoryboweldiseaserepresenlunmelnecds.Nowfirst-in-classdrugsmightbediscoveredinthefuturebutandfurtherdevelopmentofolddrugsalsoofferspromisefortheseconditions.ThisisstilltherepurposethecaseoftheKeywords:ACTHDru4、gdiscoveiyGPCRInflammationMclanocortinPro-resolvingmediatorinelanocortinadrenocorticoiropinhormono,ACTH,usedinpatientssince1952butregardedasthelasttherapeuticoptionwhenothermedicationssuchasglucocorticoids>cannolbcuscd・Betterunderstand-ingonitsphvsiologicalandpha5、rmacologicalmechanismsofactionsaminewinsightsonmclanocortinreceptorsbiologyhaverevivedtheinterestonrescuingthisoldandeffectivcdrug.ACTIIdoesnotonlyinducecortisolproductionfaspreviouslyassumed,butitalsoexertsanti-inflammatoryactionsbytarget-ingme!anocortinreceptor6、spresentonimmunccellaThecndogenousagonistsf'orthesereceptors(ACTH,CZhLhandO-melanocytestimulatinghormones),arealsoproducedlocallybyimmunecellsindicatingthcexisteneeofanendogenousanii-inflammalorytissue-protectivecircuitinvolvingthemelanocortinsyslem.Thesefiriding7、ssuggeslcdlhalriewACTIl-likemelAnocorlindrugsdcvoidofsleroidogenicaction%andhencosidecffeclscouldbedeveloped・ThisreviewsuinmarizestheadionsofACTHandmelanocortindrugs,theirroleasendogenouspro-resolvingmcdiatorstheircurrentclinicaluseandprovidesanoverviewonhowrecen8、iadvancesonGPCRfunctioningmayleadloanovelclassofdrugs.^20IoKlscvierl.idAllrightsreserved1.IiiltoduclionDoweneednewdrugstoLreathumandiseases?Doweneednovellherap
2、iversityofl.ondon,ChartcrhouseSquaraEC1M6BQ.London,UniledKingdomarticleinfoArLiclehistory:Received14January2015Received!nrevisedform7February2015Accepted9February2015Althoughanti-inflammalorydrugsarcamongthemostcommonclassofmarketeddrugschronicinflam-matorycondit
3、ionssuchasrheumatoidarthritismultiplesclerosisorinflammatoryboweldiseaserepresenlunmelnecds.Nowfirst-in-classdrugsmightbediscoveredinthefuturebutandfurtherdevelopmentofolddrugsalsoofferspromisefortheseconditions.ThisisstilltherepurposethecaseoftheKeywords:ACTHDru
4、gdiscoveiyGPCRInflammationMclanocortinPro-resolvingmediatorinelanocortinadrenocorticoiropinhormono,ACTH,usedinpatientssince1952butregardedasthelasttherapeuticoptionwhenothermedicationssuchasglucocorticoids>cannolbcuscd・Betterunderstand-ingonitsphvsiologicalandpha
5、rmacologicalmechanismsofactionsaminewinsightsonmclanocortinreceptorsbiologyhaverevivedtheinterestonrescuingthisoldandeffectivcdrug.ACTIIdoesnotonlyinducecortisolproductionfaspreviouslyassumed,butitalsoexertsanti-inflammatoryactionsbytarget-ingme!anocortinreceptor
6、spresentonimmunccellaThecndogenousagonistsf'orthesereceptors(ACTH,CZhLhandO-melanocytestimulatinghormones),arealsoproducedlocallybyimmunecellsindicatingthcexisteneeofanendogenousanii-inflammalorytissue-protectivecircuitinvolvingthemelanocortinsyslem.Thesefiriding
7、ssuggeslcdlhalriewACTIl-likemelAnocorlindrugsdcvoidofsleroidogenicaction%andhencosidecffeclscouldbedeveloped・ThisreviewsuinmarizestheadionsofACTHandmelanocortindrugs,theirroleasendogenouspro-resolvingmcdiatorstheircurrentclinicaluseandprovidesanoverviewonhowrecen
8、iadvancesonGPCRfunctioningmayleadloanovelclassofdrugs.^20IoKlscvierl.idAllrightsreserved1.IiiltoduclionDoweneednewdrugstoLreathumandiseases?Doweneednovellherap
此文档下载收益归作者所有